Posted by Michael Wonder on 25 Nov 2015
FDA approves vaccine for use after known or suspected anthrax exposure
24 November 2015 - The vaccine’s new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment.
For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm474027.htm
